Summary
The product Modvigil 200 mg, manufactured by HAB Pharmaceuticals, was tested to verify its composition and potency. Submitted and funded by Modawhale, the sample was analyzed by Janoshik Analytical, a recognized laboratory for pharmaceutical testing. The analysis confirmed the presence of modafinil at a measured concentration of 198.86 mg per tablet, reflecting a 0.57% variance below the labeled specification of 200 mg.
The testing process was initiated on 31 October 2024, the sample was received on 5 November 2024, and the analysis was completed on 11 November 2024. The results demonstrate that the product closely adheres to its labeled claim, although independent third-party testing of market-acquired samples is recommended to validate consistency across batches.
Detailed Report
Product Overview
- Manufacturer: HAB Pharmaceuticals
- Product Name: Modvigil 200 mg
- Active Ingredient: Modafinil
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral tablet
Sample Acquisition and Testing
- Task Number: #52188
- Testing Ordered: 31 October 2024
- Sample Received: 5 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Modawhale (Reseller)
- Analysis Paid For By: Modawhale
Testing Results
- Specification: 200 mg (as stated on the label)
- Measured Concentration: 198.86 mg
- Accuracy: 99.43% (0.57% below the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/52188_EVDMCFFMX2GJ
- Originally Published: https://thinksteroids.com/community/posts/3373596/
Evaluation of Reseller-Submitted Testing
The test results show a minimal 0.57% deviation below the labeled claim, indicating reliable manufacturing practices by HAB Pharmaceuticals. However, since the sample was submitted and funded by Modawhale, potential biases from selective sample submission must be considered. Independent testing of market-acquired samples would provide greater assurance of consistency across different batches.
Conclusion
The analysis confirms that Modvigil 200 mg closely aligns with its labeled claim, with a measured concentration of 198.86 mg modafinil, reflecting a minor deviation of 0.57% below the stated dosage. While this result demonstrates strong quality control, independent testing remains critical to verify consistency and mitigate potential bias associated with reseller-submitted samples.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may involve inherent biases due to selective sample submissions. The findings pertain solely to the tested batch and may not represent all products under the same name. Readers are encouraged to cross-reference these results with independent third-party testing for additional validation and use this information responsibly.
